Current Oncology (Mar 2024)

PC-PEP, a Comprehensive Daily Six-Month Home-Based Patient Empowerment Program Leads to Weight Loss in Men with Prostate Cancer: A Secondary Analysis of a Clinical Trial

  • Wyatt MacNevin,
  • Gabriela Ilie,
  • Ricardo Rendon,
  • Ross Mason,
  • Jesse Spooner,
  • Emily Chedrawe,
  • Nikhilesh Patil,
  • David Bowes,
  • Greg Bailly,
  • David Bell,
  • Derek Wilke,
  • Jeffery B. L. Zahavich,
  • Cody MacDonald,
  • Robert David Harold Rutledge

DOI
https://doi.org/10.3390/curroncol31030127
Journal volume & issue
Vol. 31, no. 3
pp. 1667 – 1688

Abstract

Read online

Background: The Prostate Cancer—Patient Empowerment Program (PC-PEP) is a six-month daily home-based program shown to improve mental health and urinary function. This secondary analysis explores weight loss in male PC-PEP participants. Methods: In a randomized clinical trial with 128 men undergoing curative prostate cancer (PC) treatment, 66 received ‘early’ PC-PEP, while 62 were assigned to the ‘late’ waitlist-control group, receiving 6 months of standard-of-care treatment followed by 6 months of PC-PEP. PC-PEP comprised 182 daily emails with video-based exercise and dietary (predominantly plant-based) education, live online events, and 30 min strength training routines (using body weight and elastic bands). Weight and height data were collected via online surveys (baseline, 6 months, and 12 months) including medical chart reviews. Adherence was tracked weekly. Results: No attrition or adverse events were reported. At 6 months, the early PC-PEP group experienced significant weight loss, averaging 2.7 kg (p Conclusions: PC-PEP led to significant weight loss in men undergoing curative prostate cancer treatment compared to standard-of-care.

Keywords